| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of Novel Cytotoxic Agents in Lung Cancer: Epothilones and Topoisomerase I Inhibitors
|
Wakelee, Heather A.
|
|
2005
|
7 |
Supplement 1 |
p. S6-S12
7 p.
|
artikel
|
| 2 |
Asian Ethnicity as a Predictor of Response in Patients with Non–Small-Cell Lung Cancer Treated with Gefitinib on an Expanded Access Program
|
Thomas, Sheeba K.
|
|
2006
|
7 |
Supplement 1 |
p. 326-331
6 p.
|
artikel
|
| 3 |
Computed Tomography Screening for Lung Cancer: Prospects of Surviving Competing Causes of Death
|
Henschke, Claudia I.
|
|
2006
|
7 |
Supplement 1 |
p. 323-325
3 p.
|
artikel
|
| 4 |
Continuous-Infusion Vinorelbine for the Treatment of Advanced Non–Small-Cell Lung Cancer: A Phase I/II Study
|
Carabante-Ocôn, Francisco
|
|
2005
|
7 |
Supplement 1 |
p. 121-126
6 p.
|
artikel
|
| 5 |
Current Status of Mammalian Target of Rapamycin Inhibitors in Lung Cancer
|
Gómez-Martín, Carlos
|
|
2005
|
7 |
Supplement 1 |
p. S13-S18
6 p.
|
artikel
|
| 6 |
Efficacy and Safety of Paclitaxel Poliglumex as First-Line Chemotherapy in Patients at High Risk with Advanced-Stage Non–Small-Cell Lung Cancer: Results of a Phase II Study
|
Richards, Donald A.
|
|
2005
|
7 |
Supplement 1 |
p. 215-220
6 p.
|
artikel
|
| 7 |
Gemcitabine/Carboplatin in Patients with Metastatic Non–Small-Cell Lung Cancer: Phase II Study of 28-Day and 21-Day Schedules
|
Obasaju, Coleman K.
|
|
2005
|
7 |
Supplement 1 |
p. 202-207
6 p.
|
artikel
|
| 8 |
Interactions Between Hypoxia and Epidermal Growth Factor Receptor in Non–Small-Cell Lung Cancer
|
Swinson, Daniel Edmund Bryan
|
|
2006
|
7 |
Supplement 1 |
p. 250-256
7 p.
|
artikel
|
| 9 |
Multicenter Phase II Trial of Carboplatin/Vinorelbine in Elderly Patients with Advanced Non–Small-Cell Lung Cancer–Efficacy and Impact on Quality of Life: Groupe Français de Pneumo-Cancérologie Study 9902
|
LeCaer, Hervé
|
|
2005
|
7 |
Supplement 1 |
p. 114-120
7 p.
|
artikel
|
| 10 |
Multicenter Randomized Trial for Stage IIIB/IV Non–Small-Cell Lung Cancer Using Every-3-Week Versus Weekly Paclitaxel/Carboplatin
|
Schuette, Wolfgang
|
|
2006
|
7 |
Supplement 1 |
p. 338-343
6 p.
|
artikel
|
| 11 |
Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program
|
Jänne, Pasi A.
|
|
2005
|
7 |
Supplement 1 |
p. 40-46
7 p.
|
artikel
|
| 12 |
Phase II Data with ZD6474, a Small-Molecule Kinase Inhibitor of Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor, in Previously Treated Advanced Non–Small-Cell Lung Cancer
|
Lee, David
|
|
2005
|
7 |
Supplement 1 |
p. 89-91
3 p.
|
artikel
|
| 13 |
Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer
|
Schuette, Wolfgang
|
|
2005
|
7 |
Supplement 1 |
p. 133-137
5 p.
|
artikel
|
| 14 |
Prognostic Role of Protease-Activated Receptors 1 and 4 in Resected Stage IB Non-Small-Cell Lung Cancer
|
Ghio, Paulo
|
|
2006
|
7 |
Supplement 1 |
p. 395-400
6 p.
|
artikel
|
| 15 |
Pulmonary Dysfunction as a Major Cause of Inoperability Among Patients with Non–Small-Cell Lung Cancer
|
Baser, Sevin
|
|
2006
|
7 |
Supplement 1 |
p. 344-349
6 p.
|
artikel
|
| 16 |
Randomized Multicenter Phase II Study of Gemcitabine Versus Docetaxel as First-Line Therapy with Second-Line Crossover in Advanced-Stage Non–Small-Cell Lung Cancer
|
Manegold, Christian
|
|
2005
|
7 |
Supplement 1 |
p. 208-214
7 p.
|
artikel
|
| 17 |
Relevance of Epidermal Growth Factor Receptor Genomic Gain in Predicting Clinical Response to Kinase Inhibitors in Non–Small-Cell Lung Cancer
|
Reddy, G. Kesava
|
|
2005
|
7 |
Supplement 1 |
p. 163-165
3 p.
|
artikel
|
| 18 |
Second-Line Chemotherapy with a Modified Schedule of Docetaxel in Elderly Patients with Advanced-Stage Non-Small-Cell Lung Cancer
|
Tibaldi, Carmelo
|
|
2006
|
7 |
Supplement 1 |
p. 401-405
5 p.
|
artikel
|
| 19 |
Selected Clinical Trials in Lung Cancer
|
|
|
2006
|
7 |
Supplement 1 |
p. 288-
1 p.
|
artikel
|
| 20 |
Sequential Versus Alternating Administration of Cisplatin/Etoposide and Topotecan as First-Line Treatment in Extensive-Stage Small-Cell Lung Cancer: Preliminary Results of a Phase III Trial of the Hellenic Oncology Research Group
|
Ignatiadis, Michail
|
|
2005
|
7 |
Supplement 1 |
p. 183-189
7 p.
|
artikel
|
| 21 |
Single-Agent Gefitinib in Patients with Untreated Advanced Non–Small-Cell Lung Cancer and Poor Performance Status: A Minnie Pearl Cancer Research Network Phase II Trial
|
Spigel, David R.
|
|
2005
|
7 |
Supplement 1 |
p. 127-132
6 p.
|
artikel
|
| 22 |
Topotecan in the Treatment of Elderly Patients with Relapsed Small-Cell Lung Cancer
|
Garst, Jennifer
|
|
2005
|
7 |
Supplement 1 |
p. 190-196
7 p.
|
artikel
|
Tijdschrift beschrijving